AbbVie Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $3.95B | $8.40B |
| FY2016 | — | $4.64B | $5.10B |
| FY2017 | — | $5.10B | $9.30B |
| FY2018 | — | $-8.45B | $7.29B |
| FY2019 | $67.23B | $-8.17B | $39.92B |
| FY2020 | $84.95B | $13.08B | $8.45B |
| FY2021 | $75.96B | $15.41B | $9.75B |
| FY2022 | $63.13B | $17.25B | $9.20B |
| FY2023 | $59.25B | $10.36B | $12.81B |
| FY2024 | $66.84B | $3.33B | $5.52B |